The anti-staphylococcal activity (planktonic and biofilm) of Cnestis ferruginea is due to benzoquinone, the oxidation product of hydroquinone.

IF 4.6 2区 医学 Q2 IMMUNOLOGY
Frontiers in Cellular and Infection Microbiology Pub Date : 2025-01-17 eCollection Date: 2024-01-01 DOI:10.3389/fcimb.2024.1494589
Sujogya Kumar Panda, Michelle Reynders, Purity N Kipanga, Walter Luyten
{"title":"The anti-staphylococcal activity (planktonic and biofilm) of <i>Cnestis ferruginea</i> is due to benzoquinone, the oxidation product of hydroquinone.","authors":"Sujogya Kumar Panda, Michelle Reynders, Purity N Kipanga, Walter Luyten","doi":"10.3389/fcimb.2024.1494589","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>Cnestis ferruginea</i> is used frequently in African traditional medicine for treating infectious diseases. Previous bioassay-guided purification has identified hydroquinone as the major bio-active compound in the aforementioned plant, responsible for its antibacterial activity against <i>Staphylococcus aureus</i>. While the phenol hydroquinone can be directly extracted from the plant, it may undergo (reversible) oxidation under mild conditions to yield benzoquinone, a compound with known antimicrobial activity against <i>i.a. S. aureus</i>.</p><p><strong>Methods: </strong>We, examined whether hydroquinone or its oxidation product, benzoquinone, is the active compound against bacteria such as <i>S. aureus</i>. To achieve this we performed broth microdilution (planktonic) and biofilm activity tests against two different strains of <i>S. aureus</i>. The inhibitory concentrations (IC<sub>50</sub>) of benzoquinone and hydroquinone under various circumstances were compared, assessing their stability, and examining their effectiveness against two strains of <i>S. aureus</i> (Rosenbach and USA 300) in both planktonic and biofilm environments.</p><p><strong>Results: </strong>Benzoquinone demonstrated antibacterial activity against <i>S. aureus</i> Rosenbach and USA 300 with IC<sub>50</sub> of 6.90 ± 2.30 mM and 7.72 ± 2.73 mM, respectively, while the corresponding values for hydroquinone were 15.63 ± 2.62 mM and 19.21 ± 4.84 mM, respectively. However, when oxidation was prevented by the addition of antioxidants such as ascorbic acid or glutathione, hydroquinone lost its antibacterial property, while benzoquinone retained activity. Comparing conditions in which hydroquinone could convert into benzoquinone against conditions in which this conversion was inhibited, showed that hydroquinone alone did not inhibit bacterial growth of <i>S. aureus</i>, while benzoquinone alone did.</p><p><strong>Discussion: </strong>These results prove that the oxidation product benzoquinone is responsible for the antimicrobial activity previously ascribed to hydroquinone.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1494589"},"PeriodicalIF":4.6000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782209/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular and Infection Microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcimb.2024.1494589","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cnestis ferruginea is used frequently in African traditional medicine for treating infectious diseases. Previous bioassay-guided purification has identified hydroquinone as the major bio-active compound in the aforementioned plant, responsible for its antibacterial activity against Staphylococcus aureus. While the phenol hydroquinone can be directly extracted from the plant, it may undergo (reversible) oxidation under mild conditions to yield benzoquinone, a compound with known antimicrobial activity against i.a. S. aureus.

Methods: We, examined whether hydroquinone or its oxidation product, benzoquinone, is the active compound against bacteria such as S. aureus. To achieve this we performed broth microdilution (planktonic) and biofilm activity tests against two different strains of S. aureus. The inhibitory concentrations (IC50) of benzoquinone and hydroquinone under various circumstances were compared, assessing their stability, and examining their effectiveness against two strains of S. aureus (Rosenbach and USA 300) in both planktonic and biofilm environments.

Results: Benzoquinone demonstrated antibacterial activity against S. aureus Rosenbach and USA 300 with IC50 of 6.90 ± 2.30 mM and 7.72 ± 2.73 mM, respectively, while the corresponding values for hydroquinone were 15.63 ± 2.62 mM and 19.21 ± 4.84 mM, respectively. However, when oxidation was prevented by the addition of antioxidants such as ascorbic acid or glutathione, hydroquinone lost its antibacterial property, while benzoquinone retained activity. Comparing conditions in which hydroquinone could convert into benzoquinone against conditions in which this conversion was inhibited, showed that hydroquinone alone did not inhibit bacterial growth of S. aureus, while benzoquinone alone did.

Discussion: These results prove that the oxidation product benzoquinone is responsible for the antimicrobial activity previously ascribed to hydroquinone.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.90
自引率
7.00%
发文量
1817
审稿时长
14 weeks
期刊介绍: Frontiers in Cellular and Infection Microbiology is a leading specialty journal, publishing rigorously peer-reviewed research across all pathogenic microorganisms and their interaction with their hosts. Chief Editor Yousef Abu Kwaik, University of Louisville is supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Cellular and Infection Microbiology includes research on bacteria, fungi, parasites, viruses, endosymbionts, prions and all microbial pathogens as well as the microbiota and its effect on health and disease in various hosts. The research approaches include molecular microbiology, cellular microbiology, gene regulation, proteomics, signal transduction, pathogenic evolution, genomics, structural biology, and virulence factors as well as model hosts. Areas of research to counteract infectious agents by the host include the host innate and adaptive immune responses as well as metabolic restrictions to various pathogenic microorganisms, vaccine design and development against various pathogenic microorganisms, and the mechanisms of antibiotic resistance and its countermeasures.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信